Zhi-Fen Pan
6 Papers
Zhi-Fen Pan is an academic researcher. The author has contributed to research in topics: Internal medicine & Randomized controlled trial. The author has an hindex of 5, co-authored 5 publications.
Chat about Author
Papers
Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS.
Dandan Xu,Yanyuan Li,Xiang Li,Li-Liang Wei,Zhi-Fen Pan,Tingting Jiang,Zhong-Liang Chen,Chong Wang,Wen-Ming Cao,Xing Zhang,Ze-Peng Ping,Chang-Ming Liu,Jiyan Liu,Zhong-Jie Li,Ji-Cheng Li +14 more
TL;DR: The results showed that S100A9, SOD3, and MMP9 may be potential diagnostic biomarkers for pulmonary TB, and provided experimental basis for the diagnosis of pulmonary TB.
77
A Group of Novel Serum Diagnostic Biomarkers for Multidrug-Resistant Tuberculosis by iTRAQ-2D LC-MS/MS and Solexa Sequencing.
Chong Wang,Chang-Ming Liu,Li-Liang Wei,Li-Ying Shi,Zhi-Fen Pan,Lian-Gen Mao,Xiao-Chen Wan,Ze-Peng Ping,Tingting Jiang,Zhong-Liang Chen,Zhong-Jie Li,Ji-Cheng Li +11 more
TL;DR: This study proposes potential biomarkers for MDR-TB diagnosis, and provides a new experimental basis to understand the pathogenesis of MDR, especially multidrug-resistance tuberculosis.
Association of the miR-146a, miR-149, miR-196a2 and miR-499 polymorphisms with susceptibility to pulmonary tuberculosis in the Chinese Uygur, Kazak and Southern Han populations
Xing Zhang,Yanyuan Li,Xiang Li,Wanjiang Zhang,Zhi-Fen Pan,Fang Wu,Chong Wang,Zhong-Liang Chen,Tingting Jiang,Dandan Xu,Ze-Peng Ping,Jiyan Liu,Chang-Ming Liu,Zhong-Jie Li,Ji-Cheng Li +14 more
TL;DR: The results suggested that susceptibility to pulmonary TB may be closely related to individual differences caused by genetic factors among different ethnic groups in China.
Randomized Control Study of the Use of Faropenem for Treating Patients with Pulmonary Tuberculosis.
Yanwan Shangguan,Wanru Guo,Xuewen Feng,Yunzhen Shi,Xiaomeng Li,Zhi-Fen Pan,M D Hu,Jichan Shi,Cheng Ding,Jiafeng Xia,Wenjuan Hu,Zhongkang Ji,Chen-Mei Zhao,Yue Li,Zebao He,Lingxiao Jin,Xiao-Hong Tao,Xiaoqiang Zhang,Qun Song,Yuyin Zhu,Li-Hua Zheng,Xiuyuan Jin,Shu-juan Huang,Liang-mei Jiang,Tiantian Wu,Danong Cao,Ying Zhang,Lanjuan Li,Kaijin Xu +28 more
TL;DR: In this paper , the authors conducted an open-label, randomized trial in China, involving newly diagnosed, drug-susceptible pulmonary TB patients, where the experimental group replaced ethambutol with faropenem for 2 months and the control group was treated with the standard 6-month regimen.
Screening and identification of five serum proteins as novel potential biomarkers for cured pulmonary tuberculosis.
Chong Wang,Li-Liang Wei,Li-Ying Shi,Zhi-Fen Pan,Xiao-Mei Yu,Tian-Yu Li,Chang-Ming Liu,Ze-Peng Ping,Tingting Jiang,Zhong-Liang Chen,Lian-Gen Mao,Zhong-Jie Li,Ji-Cheng Li +12 more
TL;DR: The results indicated that ALB, ARHGDIB, C3, FCN2, and LPA levels might serve as potential biomarkers for cured TB and also proposes potential markers for evaluating the efficacy of anti-TB drugs.